The hearing implant maker’s share price cratered to the lowest level since April 2016 after it warned that softer global sales would hit its bottom line.
Cochlear’s shares have collapsed after the hearing implants behemoth again downgraded profit guidance by up to $170m on deteriorating global consumer sentiment and the Middle East conflict.
One day can ruin years of success... The post Cochlear stock down 40%: How much has this cost ASX investors? appeared first on The Motley Fool Australia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results